Fda Catalyst Medicines

CDER-track catalyst analysis for medicines: PDUFA target dates, AdCom votes, sNDA/sBLA label expansions, biosimilar interchangeability and 180-day exclusivity, Orange Book state, and CRL remediation timelines — enumerated, verified, and sized per event for any biotech/pharma ticker or watchlist.

agentii-ai Updated 210 repo stars

File contents

agentii-ai/agentii-investment-intelligence commit 2659ddd8bc

Frequently asked questions

npx get-skill add agentii-ai/fda-catalyst-medicines